Restoring Pancreatic Function with Stem Cells in Diabetes: An Outcomes Review
Background / Problem
Diabetes is the most common non-communicable disease in Thailand, affecting about 8.9% of the population. It arises when the body cannot produce or use insulin properly, causing chronically high blood sugar.
Chronic hyperglycemia leads to complications affecting the heart, brain, kidneys, retina, and peripheral nerves, and people with diabetes have roughly a 50% higher risk of mortality than those without it. This piece reviews the role of stem cells as an emerging approach aimed at restoring pancreatic function.
Approach & Mechanism
A key pathology of diabetes is the body's inability to produce sufficient insulin. Stem cell therapy therefore aims to regenerate and replace dysfunctional pancreatic cells so they can produce insulin again. Studies have explored stem cells from multiple sources — bone marrow and adipose tissue — with generally consistent results.
- 1Begin with first-line care: dietary control, weight loss, and exercise
- 2Use glucose-lowering medication and insulin replacement as needed
- 3Explore emerging technologies such as nanotechnology insulin delivery and gene therapy
- 4Study stem cells to regenerate pancreatic cells, alongside self-care
Outcomes
Several studies have shown a trend toward reduced dependence on insulin injections among patients treated with stem cells. However, many of these approaches remain in the research and patient-trial phase, so patients should receive first-line treatment and make lifestyle changes in parallel for sustainable outcomes.
- Stem cells aim to regenerate and replace dysfunctional pancreatic cells
- Research reports a trend toward reduced dependence on insulin injections
- Many methods are still in research; they should complement primary care and lifestyle change
Key Findings / Insights
- Stem cells may help restore the function of insulin-producing pancreatic cells
- Treatment should be paired with diet control and self-care for sustainable results
- Long-term studies are needed to assess the durability of the effect
References
- Diabetes Association of Thailand. Clinical Practice Guideline for Diabetes 2017. 2017. https://www.dmthai.org/attachments/article/443/guideline-diabetes-care-2017.pdf
- Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. Diabetes 2030: insights from yesterday, today, and future trends. Population Health Management. 2017;20(1):6-12.
- Tiwari P. Recent trends in therapeutic approaches for diabetes management: a comprehensive update. Journal of Diabetes Research. 2015;2015:340838.
- Jiang R, Han Z, Zhuo G, et al. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Frontiers of Medicine. 2011;5(1):94-100.
- Bhansali A, Asokumar P, Walia R, et al. Efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus: a randomized placebo-controlled study. Cell Transplantation. 2014;23(9):1075-85.
Related Resources
Frequently Asked Questions (FAQs)
Can stem cell therapy for diabetes eliminate the need for insulin?
Results vary by individual and many approaches remain under research; any change or discontinuation of medication must be done under medical supervision only.